Middle East & Africa Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The organoids market in the Middle East and Africa is projected to grow significantly, reaching approximately US$ 289.76 million by 2031, up from US$ 77.94 million in 2023, with a compound annual growth rate (CAGR) of 17.8% during this period.

Executive Summary and Market Analysis

The market is divided into several regions, including the UAE, South Africa, Saudi Arabia, and the Rest of the Middle East and Africa. The growth in this sector is primarily driven by increased research into cancer and genetic mutations, the rising adoption of disease modeling techniques, and advancements made by companies in organoid technology.

Market Segmentation

The Middle East and Africa organoids market can be analyzed through various segments: type, application, source, offering, and method.

Type: The market is categorized into organoids derived from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoids held the largest market share.
Application: The applications of organoids include developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, personalized medicine, and others. Developmental biology applications dominated the market in 2023.
Source: The market is divided into organoids derived from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells accounting for a larger share in 2023.
Offering: This segment includes instruments, consumables, and services, with consumables leading the market in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
Method: The methods used to create organoids include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion techniques, and others. The hanging drop method was the most prevalent in 2023.

Market Outlook

Organoids are 3D structures derived from stem cells that replicate the architecture and function of real organs. This innovative technology has facilitated the development of numerous human cancer models, allowing for the indefinite expansion of organoids from tumor tissues of cancer patients. Techniques such as CRISPR enable the modification of organoids to create cancer models by introducing specific genetic changes. Tumor organoids, when combined with immune cells and fibroblasts, can simulate a cancer microenvironment, which is valuable for immuno-oncology research.

Recent advancements in organoid technology have made it possible to create patient-specific 3D cultures from tumor biopsies, enhancing personalized medicine approaches. Organoids have been successfully generated from various cancers, including breast, bladder, colon, prostate, pancreas, and liver cancers, providing insights into these diseases. The introduction of tumoroid lines in vitro is paving the way for new applications in drug discovery and cancer research, with 3D cultures offering advantages over traditional 2D cell lines.

Research indicates that tumoroid culturing is effective for collecting diverse cancer subtypes from patients. As organoids can be derived from single cancer cells, they are increasingly used to replicate intratumor differentiation in laboratory settings. Companies are also developing biobanks for storing biological samples, including tumors. For example, OrganoidBase by Crown Bioscience features 342 tumor organoid models derived from patient-derived xenograft (PDX) models, providing extensive data on drug responses and genomic analyses.

Country Insights

The organoids market in the Middle East and Africa includes key countries such as Saudi Arabia, South Africa, and the UAE, with Saudi Arabia holding the largest market share in 2023. The country has seen a rise in regenerative medicine research, focusing on chronic diseases and potential treatments for metabolic disorders and cancer through cellular therapies. Government initiatives and collaborations among key players and research institutions are expected to enhance the adoption of organoid technologies in Saudi Arabia.

Saudi Arabia has made significant strides in stem cell donation, becoming the first Arab nation to register over 10,000 stem cell donors in 2015. This growth in stem cell research is anticipated to support the organoids market, especially in light of the increasing incidence of chronic diseases such as multiple sclerosis and cancer.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc., Corning Inc., Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne Corp, and others. These companies are pursuing strategies such as expansion, product innovation, and mergers to enhance their market presence and offer cutting-edge products.

Product Code: TIPRE00018855

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Middle East & Africa Organoids Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Demand for Tumor Modeling and Biobanking
- 4.1.2 Surging Adoption of Personalized Drugs
4.2 Market Restraints
- 4.2.1 Dearth of Skilled Professionals
4.3 Market Opportunities
- 4.3.1 Focus on Drug Discovery Activities
4.4 Future Trends
- 4.4.1 Combination of Organoids and Organ-on-a-Chip
4.5 Impact of Drivers and Restraints:

5. Organoids Market - Middle East & Africa Analysis

5.1 Middle East & Africa Organoids Market Revenue (US$ Million), 2021-2031
5.2 Middle East & Africa Organoids Market Forecast Analysis

6. Middle East & Africa Organoids Market Analysis - by Type

6.1 Intestine
- 6.1.1 Overview
- 6.1.2 Intestine: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Liver
- 6.2.1 Overview
- 6.2.2 Liver: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Stomach
- 6.3.1 Overview
- 6.3.2 Stomach: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Pancreas
- 6.4.1 Overview
- 6.4.2 Pancreas: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Lung
- 6.5.1 Overview
- 6.5.2 Lung: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.6 Brain
- 6.6.1 Overview
- 6.6.2 Brain: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.7 Kidney
- 6.7.1 Overview
- 6.7.2 Kidney: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.8 Others
- 6.8.1 Overview
- 6.8.2 Others: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Middle East & Africa Organoids Market Analysis - by Application

7.1 Developmental Biology Disease
- 7.1.1 Overview
- 7.1.2 Developmental Biology Disease: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Pathology of Infectious Disease
- 7.2.1 Overview
- 7.2.2 Pathology of Infectious Disease: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Regenerative Medicine
- 7.3.1 Overview
- 7.3.2 Regenerative Medicine: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
- 7.4.1 Overview
- 7.4.2 Drug Toxicity and Efficacy Testing: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
- 7.5.1 Overview
- 7.5.2 Drug Discovery and Personalized Medicine: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Organoids Market Analysis - by Source

8.1 Pluripotent Stem Cells
- 8.1.1 Overview
- 8.1.2 Pluripotent Stem Cells: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Organ-Specific Adult Stem Cell
- 8.2.1 Overview
- 8.2.2 Organ-Specific Adult Stem Cell: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Organoids Market Analysis - by Offering

9.1 Instruments
- 9.1.1 Overview
- 9.1.2 Instruments: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Consumables
- 9.2.1 Overview
- 9.2.2 Consumables: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Services
- 9.3.1 Overview
- 9.3.2 Services: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Organoids Market Analysis - by Method

10.1 Micropatterned Plates
- 10.1.1 Overview
- 10.1.2 Micropatterned Plates: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Ultralow Attachment Plates
- 10.2.1 Overview
- 10.2.2 Ultralow Attachment Plates: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Hanging Drop
- 10.3.1 Overview
- 10.3.2 Hanging Drop: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4 Microdroplet or Emulsion
- 10.4.1 Overview
- 10.4.2 Microdroplet or Emulsion: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Middle East & Africa Organoids Market - Country Analysis

11.1 Middle East & Africa
- 11.1.1 Middle East & Africa Organoids Market - Revenue and Forecast Analysis - by Country
  - 11.1.1.1 Middle East & Africa Organoids Market - Revenue and Forecast Analysis - by Country
  - 11.1.1.2 Saudi Arabia: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.2.1 Saudi Arabia: Middle East & Africa Organoids Market Share - by Type
    - 11.1.1.2.2 Saudi Arabia: Middle East & Africa Organoids Market Share - by Application
    - 11.1.1.2.3 Saudi Arabia: Middle East & Africa Organoids Market Share - by Source
    - 11.1.1.2.4 Saudi Arabia: Middle East & Africa Organoids Market Share - by Offering
    - 11.1.1.2.5 Saudi Arabia: Middle East & Africa Organoids Market Share - by Instruments
    - 11.1.1.2.6 Saudi Arabia: Middle East & Africa Organoids Market Share - by Consumables
    - 11.1.1.2.7 Saudi Arabia: Middle East & Africa Organoids Market Share - by Method
  - 11.1.1.3 South Africa: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.3.1 South Africa: Middle East & Africa Organoids Market Share - by Type
    - 11.1.1.3.2 South Africa: Middle East & Africa Organoids Market Share - by Application
    - 11.1.1.3.3 South Africa: Middle East & Africa Organoids Market Share - by Source
    - 11.1.1.3.4 South Africa: Middle East & Africa Organoids Market Share - by Offering
    - 11.1.1.3.5 South Africa: Middle East & Africa Organoids Market Share - by Instruments
    - 11.1.1.3.6 South Africa: Middle East & Africa Organoids Market Share - by Consumables
    - 11.1.1.3.7 South Africa: Middle East & Africa Organoids Market Share - by Method
  - 11.1.1.4 United Arab Emirates: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.4.1 United Arab Emirates: Middle East & Africa Organoids Market Share - by Type
    - 11.1.1.4.2 United Arab Emirates: Middle East & Africa Organoids Market Share - by Application
    - 11.1.1.4.3 United Arab Emirates: Middle East & Africa Organoids Market Share - by Source
    - 11.1.1.4.4 United Arab Emirates: Middle East & Africa Organoids Market Share - by Offering
    - 11.1.1.4.5 United Arab Emirates: Middle East & Africa Organoids Market Share - by Instruments
    - 11.1.1.4.6 United Arab Emirates: Middle East & Africa Organoids Market Share - by Consumables
    - 11.1.1.4.7 United Arab Emirates: Middle East & Africa Organoids Market Share - by Method
  - 11.1.1.5 Rest of Middle East & Africa: Middle East & Africa Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Type
    - 11.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Application
    - 11.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Source
    - 11.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Offering
    - 11.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Instruments
    - 11.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Consumables
    - 11.1.1.5.7 Rest of Middle East & Africa: Middle East & Africa Organoids Market Share - by Method

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 STEMCELL Technologies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Molecular Devices, LLC.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Definigen
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Organoid Therapeutics
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Corning Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Merck KGaA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 InSphero
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 ACRO Biosystems.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Bio-Techne Corp
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 SUN bioscience SA
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Crown Bioscience Inc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Sartorius AG
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 3D Biotek LLC
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 Prellis Biologics Inc.
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
13.18 3Dnamics Inc.
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis
- 13.18.6 Key Developments
13.19 Cellesce Ltd
- 13.19.1 Key Facts
- 13.19.2 Business Description
- 13.19.3 Products and Services
- 13.19.4 Financial Overview
- 13.19.5 SWOT Analysis
- 13.19.6 Key Developments

14. Appendix

14.1 About The Insight Partners